Governed from the Heart of Innovation

Rooted in the Cambridge innovation ecosystem and operating globally, ComplyGence Cambridge provides Executive Leadership, Regulatory Innovation, Compliance Intelligence, and Transformation Solutions across Biopharma, ATMPs, MedTech, Diagnostics, Digital Health, AI-enabled Healthcare, and Food & Beverage sectors.

We partner with organisations navigating complex regulatory, quality, operational, scientific, and technology challenges, helping transform innovation into commercially successful, scalable, and investor-ready assets.

Whether supporting an early-stage venture, scaling organisation, PE-backed business, or established global enterprise, our focus remains the same: aligning innovation, compliance, operations, and commercial objectives to accelerate growth whilst maintaining regulatory confidence.

More Than Consultancy

ComplyGence Cambridge is built on the belief that many organisations do not need more consultants—they need access to experienced leadership.

Through interim, fractional, and strategic advisory engagements, we provide embedded executive capability across Regulatory Affairs, CMC, Quality, Operations, Supply Chain, Technology, and Business Transformation. We work alongside leadership teams to bridge capability gaps, strengthen decision-making, accelerate execution, and deliver measurable outcomes.

Our support ranges from short-term leadership cover and transformation programmes through to long-term fractional appointments providing sustained strategic oversight and hands-on delivery.

Turning Compliance into a Strategic Asset

Our philosophy: Compliance should create Competitive Advantage.

Rather than deploying burdensome or overly complex systems, we design risk-based, digitally enabled operating models that strengthen governance, improve agility, reduce complexity, and support commercial velocity.

Our expertise spans pharmaceuticals, biologics, vaccines, ATMPs, medical devices, IVDs, SaMD, AI/ML-enabled technologies, diagnostics, and combination products. We support organisations across product development, CMC strategy, technology transfer, operational scale-up, market access, inspection readiness, remediation, M&A integration, and lifecycle management.

Regulatory Innovation & Emerging Technologies

Increasingly, our work centres on Regulatory Innovation, AI Governance, Digital Quality Ecosystems, Data Integrity, Automation, Computerised Systems, and the practical adoption of emerging technologies within highly regulated environments.

We help organisations align innovation, regulatory expectations, validation requirements, and commercial objectives to accelerate approvals, create sustainable competitive advantage, and unlock new opportunities for growth.

Our extensive experience engaging with prominent governing authorities like FDA, EMA, MHRA, designated Competent Authorities, and Notified Bodies alike supports accelerated development pathways, regulatory innovation strategies, and global market access.

Building Enterprise Value

Strong governance does more than satisfy regulators—it strengthens organisations.

We help clients improve operational maturity, strengthen asset value, enhance due diligence readiness, and build scalable operating models that increase investor confidence and support funding, partnering, licensing, acquisition, and integration activities.

The Outcome

Resilient organisations capable of innovating with confidence, navigating regulatory complexity, scaling efficiently, attracting investment, and creating sustainable commercial value.